financetom
Business
financetom
/
Business
/
Vontier Says Costco Selected Invenco Payment Systems at Canadian Fueling Sites
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vontier Says Costco Selected Invenco Payment Systems at Canadian Fueling Sites
Sep 11, 2024 6:52 AM

09:27 AM EDT, 09/11/2024 (MT Newswires) -- Vontier ( VNT ) said Wednesday that Costco Wholesale ( COST ) has selected its Invenco by GVR technology to implement payment systems at all 76 of its fueling sites in Canada, starting in October.

Financial terms were not provided.

Vontier ( VNT ) said Invenco will deploy the FlexPay 6 outdoor payment terminal and the iNFX microservices architecture, allowing over-the-air updates, improved security, and integration with third-party systems.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioCryst Pharma Q3 operating profit up, raises FY ORLADEYO sales guidance 
BioCryst Pharma Q3 operating profit up, raises FY ORLADEYO sales guidance 
Nov 3, 2025
Overview * BioCryst Q3 operating profit increased 285% y-o-y, reflecting strong leverage * ORLADEYO Q3 revenue up 37% y-o-y, driven by strong patient demand * Company raises FY 2025 ORLADEYO revenue guidance Outlook * BioCryst raises FY 2025 ORLADEYO revenue guidance to $590-$600 mln * Company lowers FY 2025 non-GAAP operating expenses to $430-$440 mln * Company expects positive cash...
Karyopharm Therapeutics' Q3 net loss widens
Karyopharm Therapeutics' Q3 net loss widens
Nov 3, 2025
Overview * Karyopharm Q3 total revenue rises to $44 mln, driven by XPOVIO sales growth * Net loss for Q3 2025 was $33.1 mln, slightly higher than last year * Company reaffirms full-year 2025 revenue guidance of $140 mln to $155 mln Outlook * Karyopharm reaffirms 2025 total revenue guidance of $140 mln to $155 mln * Company expects 2025...
Mobility tech firm ECARX turns profitable on higher shipment volumes in Q3 
Mobility tech firm ECARX turns profitable on higher shipment volumes in Q3 
Nov 3, 2025
Overview * ECARX ( ECX ) Q3 revenue grows 11% YoY to $219.9 mln, driven by higher shipment volumes * Company achieves first net profit of $0.9 mln, compared to a loss last year * Adjusted EBITDA reaches $8.3 mln, reflecting improved operational efficiency Outlook * ECARX ( ECX ) expects to maintain growth momentum into next quarter and beyond...
TG Therapeutics Q3 revenue up on strong demand, raises 2025 forecast
TG Therapeutics Q3 revenue up on strong demand, raises 2025 forecast
Nov 3, 2025
Overview * TG Therapeutics Q3 2025 revenue was $161.7 mln, driven by BRIUMVI sales * Company raises 2025 global revenue target to $600 mln, BRIUMVI U.S. target to $585 mln * Completed $100 mln share repurchase, authorized additional $100 mln program Outlook * TG Therapeutics ( TGTX ) raises 2025 global revenue target to $600 mln * Company increases 2025...
Copyright 2023-2026 - www.financetom.com All Rights Reserved